All News ViroGates A/S

Equities

VIRO

DK0061030574

Market Closed - Nasdaq Copenhagen Other stock markets 07:15:06 03/05/2024 pm IST			5-day change	1st Jan Change
7.38 ^DKK	+19.03%		+13.54%	+22.59%

02/05	ViroGates A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
15/04	Virogates A/S Announces the Outcome of Its Q-Submission Filing for Sobi®? Turbi Latex with the Us Food and Drug Administration	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ViroGates A/S : Interim Report, Q1 2024	02/05	PU
ViroGates announces its Interim Report for Q1, 2024: Quarterly revenue up 14% compared to Q1, 2023	02/05	AQ
ViroGates A/S Reports Earnings Results for the First Quarter Ended March 31, 2024	02/05	CI
Resolutions from the Annual General Meeting of ViroGates A/S	26/04	AQ
ViroGates announces the outcome of its Q-Submission filing for suPARnostic® TurbiLatex with the US FDA and the overall timeline for filing a submission of a 510k/“De Novo” application with the FDA	15/04	AQ
Virogates A/S Announces the Outcome of Its Q-Submission Filing for Sobi®? Turbi Latex with the Us Food and Drug Administration	15/04	CI
ViroGates gives notice to convene the Annual General Meeting on 25 April 2024	10/04	AQ
ViroGates announces its Annual Report 2023: Revenue was affected by the loss of COVID-19 customers and a difficult transition into general triage	21/03	AQ
ViroGates A/S Reports Earnings Results for the Full Year Ended December 31, 2023	21/03	CI
Subscription of shares by majority shareholder in relation to the recently completed rights emission in ViroGates A/S	21/12	AQ
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	21/12	AQ
ViroGates publishes its financial calendar for 2024	21/12	AQ
ViroGates announces financial guidance for 2024	21/12	AQ
ViroGates A/S Provides Earnings Guidance for the Year 2024	21/12	CI
ViroGates' capital raise of DKK 13.9 million and issue of 3,097,047 new shares have been registered	19/12	AQ
ViroGates announces the outcome of its rights issue	15/12	AQ
ViroGates A/S : Most interesting suPAR studies of 2023	08/12	PU
ViroGates notification of transactions by persons discharging managerial responsibilities according to MAR art. 19	07/12	AQ
ViroGates A/S : Clinical role of suPAR in the prognosis of patients in the emergency setting and its influence on risk stratification	06/12	PU
The subscription period in ViroGates’ rights issue begins today	30/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News ViroGates A/S

Equities

VIRO

DK0061030574

All News

Filters